Healthcare
In vitro diagnostics to be valued at $141.9b by 2029
In vitro diagnostics to be valued at $141.9b by 2029
Point-of-care testing is gaining popularity over traditional hospital and clinic diagnostics.
16 hours ago
APAC’s price controls, tendering processes pose risks to pharma firms
Such practices could impact revenues and market access.
4 days ago
US foreign aid cuts pressure health systems in emerging markets
At least 38% of USAID funds have been cut compared to FY 2024-25.
4 days ago
APAC’s HTA adoption to grow amidst infrastructure, talent challenges
Key markets include Indonesia, the Philippines, and Australia.
Oral proteins and peptides market to hit $24b by 2030
Its expansion is attributed to the prevalence of chronic diseases like diabetes.
Physicians divided over patient choice in biologics vs biosimilars
China’s physicians expressed the highest support amongst surveyed countries.
Singapore’s oncology landscape to advance with histotripsy technology
The approach is an ultrasound-based technique that offers a pain-free alternative.
Healthcare payers lag in digital maturity: report
AI solutions could cut costs and increase revenue for payers.
Hospitals need unified strategy vs ransomware
Healthcare was the second-most attacked sector by ransomware in the first half of 2024.
Digital platforms to enhance predictive modelling, personalised care
One key driver includes patient data integration into mobile health platforms.
Medical device firms eye sustainability amidst regulatory changes
Regulatory shifts may lead to temporary device shortages in the short term.
Medical alert systems market to double by 2032
Thanks to product performance innovations and AI integration.
Japan’s 10-year fund to boost pharmaceutical landscape
The country’s ageing population is driving demand for innovative treatments.
Japan’s medical device market to be valued at $42.9b by 2029
It is projected to surpass Germany to become the third-largest market globally.
Orthopaedic robot prices to drop 30% in five years: report
Thanks to increased market competition, tech advancements, and economies of scale.
Saudi Arabia’s pharmaceutical market to hit $16.7b by 2029
Thanks to rising investments and increased international collaboration.
South Korea, China lead degrader-antibody conjugate development: report
Companies from these countries collectively account for 19 out of 28 assets worldwide.
Most Read
1. What will drive the reinsurance sector to bag $68b in four years? 2. Hong Kong’s insurance premiums reach $83b in 2024 3. APAC’s price controls, tendering processes pose risks to pharma firms 4. Offshore wind, energy imports could spur RE deals in Southeast Asia 5. US foreign aid cuts pressure health systems in emerging marketsResource Center
Read Here
Advertise
Sign Up
Awards
Sep
25
Sep
25
Event News
IPP is driven by a passion for continuous improvement, circularity, and building a thriving, talent-focussed organisation.
Commentary
Are luxury boutique hotels the new black?